These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22358631)

  • 21. Safety assessment of biotechnology-derived pharmaceuticals: ICH and beyond.
    Serabian MA; Pilaro AM
    Toxicol Pathol; 1999; 27(1):27-31. PubMed ID: 10367669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feeding the World Today and Tomorrow: The Importance of Food Science and Technology: An IFT Scientific Review.
    Floros JD; Newsome R; Fisher W; Barbosa-Cánovas GV; Chen H; Dunne CP; German JB; Hall RL; Heldman DR; Karwe MV; Knabel SJ; Labuza TP; Lund DB; Newell-McGloughlin M; Robinson JL; Sebranek JG; Shewfelt RL; Tracy WF; Weaver CM; Ziegler GR
    Compr Rev Food Sci Food Saf; 2010 Sep; 9(5):572-599. PubMed ID: 33467827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review: production, characterization, and testing of banked mammalian cell substrates used to produce biological products.
    Schiff LJ
    In Vitro Cell Dev Biol Anim; 2005; 41(3-4):65-70. PubMed ID: 16029074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mucinous variant of columnar cell lesions.
    Verschuur-Maes AH; Van Diest PJ
    Histopathology; 2011 May; 58(6):847-53. PubMed ID: 21585423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosimilars: impact of biologic product life cycle and European experience on the regulatory trajectory in the United States.
    Ahmed I; Kaspar B; Sharma U
    Clin Ther; 2012 Feb; 34(2):400-19. PubMed ID: 22244050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging.
    Johnson BA; Kim S; Steinberg RL; de Leon AD; Pedrosa I; Cadeddu JA
    Urol Oncol; 2019 Dec; 37(12):941-946. PubMed ID: 31540830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ipsilateral pulmonary vein isolation performed by a single continuous circular lesion: role of pulmonary vein mapping during ablation.
    Fürnkranz A; Julian JK; Schmidt B; Wohlmuth P; Tilz R; Kuck KH; Ouyang F
    Europace; 2011 Jul; 13(7):935-41. PubMed ID: 21454334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonlinear mixed-effects models for modeling in vitro drug response data to determine problematic cancer cell lines.
    Abbas-Aghababazadeh F; Lu P; Fridley BL
    Sci Rep; 2019 Oct; 9(1):14421. PubMed ID: 31594982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of approaches to viral safety issues for biological products.
    Lubiniecki AS
    PDA J Pharm Sci Technol; 2011; 65(6):547-56. PubMed ID: 22294576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The Polish Task Force position statement on safety of biologic treatment with monoclonal antibodies and soluble receptors].
    Jahnz-Rozyk K; Wiesik-Szewczyk E;
    Pol Merkur Lekarski; 2014 Jul; 37(217):5-9. PubMed ID: 25154192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multi-site case study of community-clinical linkages for promoting HPV vaccination.
    Brandt HM; Vanderpool RC; Curry SJ; Farris P; Daniel-Ulloa J; Seegmiller L; Stradtman LR; Vu T; Taylor V; Zubizarreta M
    Hum Vaccin Immunother; 2019; 15(7-8):1599-1606. PubMed ID: 31158042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
    Meager A; Das RG
    J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Report of a WHO workshop on the standardization and control of antivenoms.
    Theakston RD; Warrell DA; Griffiths E
    Toxicon; 2003 Apr; 41(5):541-57. PubMed ID: 12676433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality considerations for recombinant DNA-derived biological therapeutic products: a control perspective on cytokines.
    Mire-Sluis A; Thorpe R
    BioDrugs; 1999 Jun; 11(6):367-76. PubMed ID: 18031148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007.
    Knezevic I; Stacey G; Petricciani J;
    Biologicals; 2008 May; 36(3):203-11. PubMed ID: 18218325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing.
    Barone PW; Avgerinos S; Ballard R; Brussel A; Clark P; Dowd C; Gerentes L; Hart I; Keumurian FJ; Kindermann J; Leung JC; Ly N; Mink S; Minning S; Mullberg J; Murphy M; Nöske K; Parriott S; Shum B; Wiebe ME; Springs SL
    PDA J Pharm Sci Technol; 2019; 73(2):191-203. PubMed ID: 30361281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.